halo mdc1 (Bio-Rad)
Structured Review

Halo Mdc1, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 2472 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/halo+mdc1/Filter/bio_rxiv__2025__01__10__632395-260-4-13
Average 96 stars, based on 2472 article reviews
Images
1) Product Images from "The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain"
Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain
Journal: bioRxiv
doi: 10.1101/2025.01.10.632395
Figure Legend Snippet: (A) Model of MDC1 recruitment to chromatin and HILO microscopy for single-molecule imaging. (B-C) Fluorescence gels of cell lysates from (B) U2OS and (C) RPE1 expressing HaloTagged MDC1 from its endogenous locus labeled with JFX650 HaloTag-ligand. (D-E) Static fraction of Halo-MDC1 molecules in interphase (I) and mitosis (M) derived from single-particle tracking of MDC1 in (D) U2OS and (E) RPE1 cells (N = 3 biological replicates, ≥ 20 cells per replicate, Mean ± SD, two-tailed T-test). (F-G) Diffusion coefficient of (F) mobile and (G) static Halo-MDC1 molecules in interphase (I) and mitosis (M) derived from single-particle tracking of MDC1 in U2OS cells (N = 3 biological replicates, ≥ 20 cells per replicate, Mean ± S.D., two-tailed T-test). (H-I) Diffusion coefficient of (H) mobile and (I) static Halo-MDC1 molecules in interphase (I) and mitosis (M) derived from single-particle tracking of MDC1 in RPE1 cells (N = 3 biological replicates, ≥ 20 cells per replicate, Mean ± S.D., two-tailed T-test). (J) Domain organization of MDC1, sequence alignment of the thirteen 41 amino acid PST repeats, and consensus sequence surrounding the two conserved TP sites within the PST repeats. (K) Phosphorescence imaging and protein staining of and SDS PAGE gel loaded with samples of the wild type (WT) and non-phosphorylatable (T>A) GST-tagged PST repeat domain treated with CDK1-Cyclin B and ATP γ- 32 P. (L) Images of mitotic U2OS cells with MDC1 knock-out (arrested with nocodazole) transiently expressing HaloTagged wildtype MDC1 (WT) and MDC1 variants with phospo-mimicking (T>D) and non-phosphorylatable (T>A) mutations in the TP sites within the PST repeat region.
Techniques Used: Microscopy, Imaging, Fluorescence, Expressing, Labeling, Derivative Assay, Single-particle Tracking, Two Tailed Test, Diffusion-based Assay, Sequencing, Staining, SDS Page, Knock-Out
Figure Legend Snippet: (A-C) Displacement histograms and two state fit of single particle tracking analysis of Halo-MDC1 expressed from its endogenous locus in (A,B) U2OS cells and (C) RPE1 cells. (D) Fluorescence gel of cell lysates from U2OS expressing Halo-MDC1 from its endogenous locus and U2OS ΔMDC1 cells transiently expressing the indicated HaloTagged MDC1 variants labeled with JF646 HaloTag-ligand.
Techniques Used: Single-particle Tracking, Fluorescence, Expressing, Labeling
Figure Legend Snippet: (A) Fluorescence gel of cell lysates of U2OS ΔMDC1 cells transiently expressing HaloTagged (JFX650) wildtype MDC1 and truncations of the PST repeats. (B-D) Single particle tracking analysis of HaloTagged wildtype MDC1 and truncations of the PST repeats in interphase U2OS ΔMDC1 cells including the (B) fraction of static particles and the diffusion coefficients of (C) mobile and (D) static MDC1 molecules (N = 3 biological replicates, ≥ 20 cells per replicate, Mean ± S.D.). (E-G) Single particle tracking analysis of HaloTagged wildtype MDC1 (WT), MDC1 with a deletion of the PST repeat region (ΔPST) and MDC1 variants with phospo-mimicking (T>D) and non-phosphorylatable (T>A) mutations in the TP sites within the PST repeat region in interphase U2OS ΔMDC1 cells including the (E) fraction of static particles and the diffusion coefficients of (F) mobile and (G) static MDC1 molecules (N = 3 biological replicates, ≥ 20 cells per replicate, Mean ± S.D.).
Techniques Used: Fluorescence, Expressing, Single-particle Tracking, Diffusion-based Assay
Figure Legend Snippet: (A-B) Images of fixed interphase and mitotic U2OS cells expressing Halo-MDC1 (JFX650) immuno-stained with (A) p-PST antibody #1 or (B) p-PST antibody #2 and Hoechst to label DNA. (C) Images of fixed, mitotic U2OS cells expressing Halo-MDC1 and U2OS ΔMDC1 cells stably expressing HaloTagged MDC1 (JFX650) variants untreated or treated with zeocin. Cells were immuno-stained with p-PST antibody #1 and Hoechst to label DNA. (D-E) Images of fixed U2OS cells expressing Halo-MDC1 (JFX650) (D) untreated or (E) treated with zeocin to induce DNA breaks in various phases of mitosis and early G1-Phase. Cells were immuno-stained with p-PST antibody #1, a γH2AX antibody, and Hoechst to label DNA.
Techniques Used: Expressing, Staining, Stable Transfection
Figure Legend Snippet: (A) Fluorescence gel of cell lysates from U2OS expressing Halo-MDC1 from its endogenous locus and U2OS ΔMDC1 cells expressing doxycycline (Dox.) inducible HaloTagged MDC1 variants from an expression cassette integrated using Sleeping Beauty transposase. The HaloTag was labeled with JFX650 HaloTag-ligand. (B-C) Images of fixed U2OS cells expressing Halo-MDC1 (JFX650) (B) untreated or (C) treated with zeocin to induce DNA breaks in various phases of mitosis and early G1-Phase. Cells were immuno-stained with p-PST antibody #2 and a γH2AX antibody and Hoechst to label DNA. (D) Images of fixed U2OS cells expressing Halo-MDC1 (JFX650) treated with zeocin to induce DNA breaks in various phases of mitosis and early G1-Phase. Cells were immuno-stained with antibodies against 53BP1 and γH2AX and Hoechst to label DNA.
Techniques Used: Fluorescence, Expressing, Labeling, Staining
Figure Legend Snippet: (A) Fluorescence gels of cell lysates from U2OS expressing HaloTagged MDC1 or MDC ΔPST from its endogenous locus labeled with JFX650 HaloTag-ligand. (B) Images of fixed, mitotic U2OS cells expressing HaloTagged MDC1 or MDC ΔPST from its endogenous locus untreated or treated with zeocin to introduce DNA breaks. Cells were labeled with JFX650 and Hoechst and immuno-stained with antibodies targeting TOPBP1 and γH2AX. (C) Images of fixed, mitotic U2OS cells expressing Halo-MDC1 and U2OS ΔMDC1 cells stably expressing HaloTagged MDC1 (JFX650) variants untreated or treated with zeocin. Cells were immuno-stained an antibody targeting CIP2A and stained with Hoechst to label DNA. (D) Quantification of the accumulation of knock-in HaloTagged MDC1 and MDC ΔPST at laser micro-irraditation induced DNA damage in living mitotic U2OS cells.
Techniques Used: Fluorescence, Expressing, Labeling, Introduce, Staining, Stable Transfection, Knock-In
Figure Legend Snippet: (A) Genome editing strategy to knock-in a cDNA encoding MDC1 lacking its PST repeat region into the endogenous MDC1 locus. Colored arrows indicate primer positions. (B-C) PCR using genomic DNA from clonal U2OS cell lines subjected to genome editing using the indicated primer pairs. In (B) successful genome editing of all alleles is expected to lead no product amplification due to the large insertion of the cDNA and selection cassette. In (C) successful insertion of the donor sequence is validated using a reverse primer oriented downstream of the right homology arm and a forward primer in the donor. (D) Growth curve of U2OS cells expressing Halo-MDC1 and Halo-MDC1 ΔPST from the endogenous MDC1 locus, and MDC1 knock-out cells (ΔMDC1).
Techniques Used: Knock-In, Amplification, Selection, Sequencing, Expressing, Knock-Out
Figure Legend Snippet: (A) Still images from live cell timelapse imaging of U2OS ΔMDC1 stably expressing HaloTagged MDC1 variants labeled with JFX650. (B) Quantification of the time from nuclear envelope breakdown to anaphase onset of U2OS ΔMDC1 cells stably expressing HaloTagged MDC1 variants. (C) Quantification of the time from nuclear envelope breakdown to anaphase onset, the chromosome segregation phenotype, and Halo-MDC1 expression level of U2OS ΔMDC1 cells stably expressing HaloTagged MDC1 variants labeled with JFX650. The chromosome segregation phenotype was determined by manual inspection.
Techniques Used: Imaging, Stable Transfection, Expressing, Labeling
Figure Legend Snippet: (A) Quantification of clonogenic survival assays using the PARP inhibitor olaparib of U2OS cells expressing HaloTagged MDC1 or MDC ΔPST from its endogenous locus. (N = 3 biological replicates plated in triplicate, Mean ± S.D., Two-way ANOVA) (B) Images of fixed interphase U2OS cells expressing HaloTagged MDC1 or MDC ΔPST from its endogenous locus untreated or treated with zeocin to induce DNA breaks. Cells were stained with JFX650 HaloTag-ligand and Hoechst, and immuno-labeled with antibodies targeting RAD51 and γH2AX. (C) Images of fixed interphase U2OS cells expressing Halo-MDC1 from its endogenous locus, MDC1 knock-out cells (ΔMDC1), and U2OS ΔMDC1 stably expressing HaloTagged MDC1 variants untreated or treated with zeocin to induce DNA breaks. Cells were stained with JFX650 HaloTag-ligand and Hoechst, and immuno-labeled with an antibody targeting RAD51. (D) Quantification of the number of RAD51 foci of the experiment in (C). An individual replicate is plotted on the left (red line = median, >100 cells per condition) and 3 biological replicates are plotted on the right (Median ± S.D., Two-way ANOVA). (E) Images of fixed interphase U2OS cells expressing Halo-MDC1 from its endogenous locus, MDC1 knock out cells (ΔMDC1), and U2OS ΔMDC1 cells stably expressing HaloTagged MDC1 variants untreated or treated with zeocin to induce DNA breaks. Cells were stained with JFX650 HaloTag-ligand and Hoechst, and immuno-labeled with an antibody targeting 53BP1. (F) Quantification of the number of 53BP1 foci of the experiment in (E). An individual replicate is plotted on the left (red line = median, >100 cells per condition) and 3 biological replicates are plotted on the right (Median ± S.D., Two-way ANOVA). (G-H) Quantification of the accumulation of (G) Halo-MDC1 and Halo-MDC1 ΔPST and (H) ubiquitin Reader1.0 at laser micro-irradiation induced DNA lesions in U2OS ΔMDC1 cells stably expressing indicated HaloTagged MDC1 variants (N = 10-19 cells, Mean ± 95% CI). (H) Quantification of the maximal accumulation of ubiquitin Reader1.0 at laser micro-irradiation induced DNA lesions in U2OS ΔMDC1 cells stably expressing indicated HaloTagged MDC1 variants (N = 10-19 cells, Mean ± 95% CI). (G) Quantification of HR efficiency using the DR-GFP reporter stably integrated into the AAVS1 locus of U2OS ΔMDC1 cells. I-Sce and MDC1 variants were transiently transfected (N = 3-4 biological replicates, Mean ± S.D., Two-way ANOVA).
Techniques Used: Expressing, Staining, Labeling, Knock-Out, Stable Transfection, Irradiation, Transfection
Figure Legend Snippet: (A-B) Quantification of the accumulation of (A) Halo-MDC1 or (B) Halo-MDC1 ΔPST labeled with JFX650 HaloTag-ligand and ubiquitin Reader1.0 at laser micro-irradiation induced DNA lesions in U2OS ΔMDC1 cells stably expressing indicated HaloTagged MDC1 variants (N = 16-19 cells, Mean ± S.E.M.). (C) Accumulation of ubiquitin Reader1.0 at laser micro-irradiation induced DNA lesions in U2OS ΔMDC1 cells stably expressing indicated HaloTagged MDC1 variants. Each trace represents an individual cell.
Techniques Used: Labeling, Irradiation, Stable Transfection, Expressing
Related Articles
Microscopy:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Imaging:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Fluorescence:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Expressing:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Labeling:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Derivative Assay:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Single-particle Tracking:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Two Tailed Test:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Diffusion-based Assay:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Sequencing:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Staining:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of SDS Page:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Knock-Out:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Stable Transfection:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Introduce:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Knock-In:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Amplification:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Selection:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Irradiation:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of Transfection:Article Title: The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain Article Snippet: Gels were run at 180V for ∼1 hour.Gels were run at 180V for ∼1 hour.. In-gel fluorescent detection of |